RCKT - Rocket Pharmaceuticals appoints Aaron Ondrey as CFO
2024-03-26 16:07:33 ET
More on Rocket Pharmaceuticals
- Rocket Pharmaceuticals' Promising Path In Gene Therapy
- Rocket Pharmaceuticals GAAP EPS of -$0.64 beats by $0.14
- FDA extends review period for Rocket gene therapy to June 30
- Seeking Alpha’s Quant Rating on Rocket Pharmaceuticals
- Historical earnings data for Rocket Pharmaceuticals